Determination of non-treatment with statins of high risk patients in The Netherlands

Current Medical Research and Opinion
Pieter van den HaakRon M C Herings

Abstract

To determine in the Netherlands what proportions of high risk patients with established cardiovascular disease (CVD) or diabetes mellitus type 2 (DM2) who were not treated with statins on 1 January 2007 and which characteristics were associated with non-treatment. From the IPCI GP database patients were selected who were registered with a GP on 1 January 2007 who had a history of either CVD (CVD patients), DM2 (diabetics) or both (diabetics with CVD). The proportion of patients using statins around 1 January 2007 was determined. Associations of patient characteristics with non-treatment were quantified (CVD patients and diabetics only). In all, 19 628 CVD patients, 5006 diabetics and 3767 diabetics with CVD were identified. Of these patients 71%, 54% and 45%, respectively did not use statins. These proportions were similar in the subgroups of patients with recent LDL-C measurements. Among these subgroups the vast majority of non-treated patients was eligible for statin treatment (LDL-C >2.5 mmol/l). The proportion of statin-treated patients was larger among diabetics than among CVD patients. Among CVD patients, female gender, age below 40 years, living in a deprived area, a history of CVD of less than 1 year and arrhythmia were...Continue Reading

References

Nov 15, 1993·Annals of Internal Medicine·J van der LeiJ H van Bemmel
Feb 19, 1996·The Medical Journal of Australia·L A SimonsJ Simons
May 26, 1998·JAMA : the Journal of the American Medical Association·J AvornJ LeLorier
Dec 11, 2002·JAMA : the Journal of the American Medical Association·R Brian HaynesAmit X Garg
Sep 11, 2003·European Heart Journal·Guy De BackerUNKNOWN Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
Jul 22, 2004·Current Medical Research and Opinion·Wim G GoettschRon M C Herings
May 4, 2006·British Journal of Clinical Pharmacology·Aukje K Mantel-TeeuwisseAnthonius de Boer
Feb 13, 2007·The American Journal of Cardiology·Sachin J Kamal-BahlChuck Wentworth

❮ Previous
Next ❯

Citations

Dec 17, 2009·Current Medical Research and Opinion·Stella S DaskalopoulouDimitri P Mikhailidis
Sep 19, 2014·Current Medical Research and Opinion·Vasilios G AthyrosManfredi Rizzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.